FDA hits Florida drugmakers with consent decree

Two Florida drug companies--Hill Dermaceuticals and Hill Labs--are now subject to an FDA consent decree prohibiting them from selling adulterated drugs across state lines. The agency went after the companies for "numerous deviations" from good manufacturing practices and for submitting falsified information, FDA said in a statement. Hill makes several topical prescription drugs and turns out two products on contract with Galderma. Release

Suggested Articles

California CDMO JSR Life Sciences is building a new home for two subsidiaries as it hopes to enter the competitive biologics market.

Three facts about how distributors are managing in-demand inventory.

Novartis’ latest campaign with a celebrity dance partner asks people to bust a move to raise awareness around sickle cell anemia and therapy Adakveo.